Antonia was twenty-two when she first sat across from our clinical team, and she had spent almost a quarter of her life managing a condition that lived on the part of the body hardest to conceal. Red, scaly patches across both cheeks, with itching that flared unpredictably into visible pimpling. Cosmetics could mute it on a good day. On a bad day, nothing helped.
What brought her in was not only the skin. Severe constipation had been present for some time, and — as she described it herself — the psychological toll had become as significant as the physical one. She avoided mirrors. She avoided eye contact, especially with young men. Smiling had become something to manage rather than something spontaneous. Five years of a visible, chronic dermatological condition in a young adult carries a social cost that does not show up on a skin exam, and we addressed that cost as part of the clinical picture, not a footnote to it.
The working question was not simply "how do we suppress this rash" but "what is driving keratinocyte overgrowth and inflammation in this specific patient, at this specific site, for this long."
Psoriasis is not infectious and not contagious, and it is understood clinically as an inflammatory disorder driven by overgrowth of keratinocytes in the outer skin layer. That inflammatory framing is what shaped our workup — we were less interested in describing the lesion than in identifying what was sustaining the inflammatory signal for half a decade.
The occupational and cosmetic exposure question mattered particularly here: the very products she used to hide the condition were candidates for perpetuating it.
The panel returned a clear pattern: elevated concentrations of heavy metals and xenohormones. Clinically, we attributed this most plausibly to a combination of her work environment and the cosmetics she had used for years to conceal the psoriasis itself.
Facial psoriasis is a chronic inflammatory disorder with genetic and immune components that we do not fully control. Where an exposure burden — occupational or cosmetic — is identified alongside it, that burden is a modifiable factor worth investigating and managing in its own right, even though it does not explain the full disease mechanism. It is not the only driver in every patient, and removing it does not guarantee resolution. In Antonia's case, the exposure pattern was substantial enough, and her history specific enough, to warrant managing it as a primary target rather than an incidental finding.
There is a particular irony in a concealment strategy that plausibly worsens the thing it conceals. Antonia had, for years, applied cosmetic products directly onto inflamed facial skin to manage the visible burden of her condition — and some of those same products were candidates in the xenohormone load we measured. Her severe constipation added a second axis: compromised gut transit is consistent with, and can compound, systemic inflammatory burden reaching the skin.
None of this reduces psoriasis to "just toxins." It does mean that in this patient, two modifiable exposure pathways were identifiable, measurable, and directly actionable.
We built the plan around reducing exposure load and supporting the organs responsible for clearing it, deliberately avoiding a systemic immunosuppressant as the first-line approach given her age and the identified exposure pattern.
Alongside the clinical plan, we advised discontinuing the specific cosmetic products implicated in the xenohormone assessment — a change that required her to sit with more visible skin during the treatment course before the skin itself improved, which was not an easy trade to ask a patient in her position to make.
We tracked her progress against a simple clinician-scored severity index across the visible facial area — lesion redness, scale, and itch, scored 0–10 at each visit — rather than a full-body PASI, since her disease was localised to the face.
| Time point | Redness (0–10) | Scale (0–10) | Itch (0–10) | Clinician-assessed clearance |
|---|---|---|---|---|
| Baseline | 8 | 7 | 8 | 0% |
| Week 4 | 4 | 3 | 3 | ~ 60% |
| Week 8 | 1 | 0–1 | 1 | ~ 95% |
The constipation resolved over a similar timeframe, tracking alongside the herbal and lactic-acid-bacteria component of the plan. By week eight, the facial skin had cleared to a degree Antonia had not experienced in five years.
"I felt deep shame about my face and experienced a sense of stigma. Whenever I saw other girls playfully interacting in front of a mirror, I would hide my face, wishing to disappear. Now, with my recovery, everything has changed. Despite the challenging journey, I feel that life is gradually starting to embrace me with a smile." — Antonia, patient
Ninety-five percent clearance in two months, after five years of a condition she had come to expect would define her twenties. The remaining five percent is worth naming honestly — it was not full, permanent resolution, and we told her so at the time.
A result this fast in a five-year chronic condition invites scrutiny of our own process, not just celebration of the outcome.
Neither change would likely have altered the skin outcome, but both would have given us a more complete record of what "recovery" meant for this patient.
This is not evidence that facial psoriasis is, in general, an exposure-driven condition, or that heavy-metal and xenohormone panels will identify a manageable cause in every patient who presents with it. Psoriasis has genetic and immunological underpinnings that exposure reduction alone does not address, and relapse and flare are recognised features of the disease that this case does not rule out for Antonia going forward.
What the case does show is that, in a patient with a specific and identifiable exposure history, testing for that exposure — rather than assuming the skin disease alone explains itself — opened a treatment pathway that did not require systemic immunosuppression.
The five years were not inevitable. They were, in part, unmeasured.
Every clinical relationship at Clinic82 begins with a private consultation with a member of our team — not a sales conversation. If a case here mirrors something you are living with, we would rather you talk to us.
Request a consultation